Researchers at Michigan Medicine have uncovered the molecular mechanism that drives the disease-causing effects of the most common genetic risk factor for lupus, a study suggests.
Aug 18, 2022
0
86
Pregnant women with active rheumatic disease carry a higher risk of adverse outcomes than the general population including hypertension, preeclampsia, higher cesarean section rate, small for gestational aged infants, preterm ...
Jul 18, 2022
0
2
A National Jewish Health led study recently published in Lupus finds that technology using video game-based cognitive therapy improves attention and executive functioning in patients with systemic lupus erythematosus (SLE).
Jul 14, 2022
0
2
Systemic lupus erythematosus (SLE) is an autoimmune disease that affects all the organ systems of the body. This chronic disease includes periods of illness, called flare ups, and periods of remission, when symptoms are few. ...
Jul 11, 2022
0
38
Two separate findings by a University of Houston nationally recognized expert in systemic lupus erythematosus (SLE or lupus), a chronic autoimmune disease that affects multiple organs including the kidneys, skin, joints and ...
Jun 2, 2022
0
14
Diet is unlikely to make any difference to the progression of osteoarthritis and rheumatoid arthritis, finds a review of the existing scientific evidence, published in the open access journal RMD Open.
May 31, 2022
0
13
While the quantity and quality of research that the National Institutes of Health (NIH) conducts on autoimmune diseases is impressive, a strategic plan and a well-funded office to support the coordination of all autoimmune ...
May 10, 2022
0
4
The nature of a typical clinical test for lupus nephritis (LN), an inflammation of the kidneys and a leading cause of mortality in lupus patients, is fraught with difficulty. The invasive renal biopsy can be painful and may ...
May 4, 2022
0
0
Children and young people with underlying rheumatic and musculoskeletal diseases (RMDs) are uncommonly hospitalized with COVID-19, a study of more than 600 patients under age 19 has found.
Mar 30, 2022
0
36
Dihydroartemisinin (DHA), an active metabolite of artemisinin and the most potent anti-malaria drug, is also used to treat autoimmune diseases such as systemic lupus erythematosus (SLE) and psoriasis. Since the first report ...
Mar 28, 2022
0
0
